Anthem Biosciences Limited (BOM:544449)

India flag India · Delayed Price · Currency is INR
666.70
-19.95 (-2.91%)
At close: Mar 4, 2026
-7.80%
Market Cap 374.90B
Revenue (ttm) 20.02B
Net Income (ttm) 4.85B
Shares Out n/a
EPS (ttm) 8.58
PE Ratio 77.35
Forward PE 55.72
Dividend n/a
Ex-Dividend Date n/a
Volume 17,045
Average Volume 18,570
Open 660.05
Previous Close 686.65
Day's Range 658.00 - 676.15
52-Week Range 579.45 - 873.25
Beta n/a
RSI 48.34
Earnings Date Feb 5, 2026

About Anthem Biosciences

Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial... [Read more]

Industry Commercial Physical and Biological Research
Founded 2006
Employees 1,825
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544449
Full Company Profile

Financial Performance

In fiscal year 2025, Anthem Biosciences's revenue was 18.50 billion, an increase of 30.29% compared to the previous year's 14.20 billion. Earnings were 4.51 billion, an increase of 22.86%.

Financial Statements

News

There is no news available yet.